Author: Taylor Warfield, Former Bain Manager and interviewer

Last Updated: May 2, 2026

 

Biotech consulting is a fast-growing specialty within management consulting that helps biotechnology, pharmaceutical, and life sciences companies turn scientific breakthroughs into commercial products. According to McKinsey, life sciences consulting engagements have grown by over 20% annually in recent years as drug development pipelines become more complex and regulatory demands intensify.

 

Whether you are a PhD scientist exploring business careers, an MBA student targeting healthcare consulting, or an undergraduate curious about the intersection of science and strategy, this guide covers everything you need to know. You will learn exactly what biotech consultants do, which firms hire them, what they earn, and how to prepare for biotech consulting interviews.

 

But first, a quick heads up:

 

McKinsey, BCG, Bain, and other top firms accept less than 1% of applicants every year. If you want to triple your chances of landing interviews and 8x your chances of passing them, watch my free 40-minute training.

 

What Is Biotech Consulting?

 

Biotech consulting helps life sciences companies solve complex business and scientific challenges across the entire drug development lifecycle. Consultants work with biotech startups, global pharmaceutical companies, medical device manufacturers, and healthcare investors to guide decisions around R&D strategy, regulatory planning, market access, product launches, and portfolio optimization.

 

In my experience at Bain, life sciences was one of the largest and fastest-growing practice areas. Roughly 25% of Bain's global revenue comes from healthcare and life sciences work, and that share has only increased as biotech innovation accelerates. The firms that dominate this space are not just advising on strategy. They are helping clients navigate FDA approvals, price therapies for global markets, and decide which pipeline assets to invest billions of dollars into.

 

Biotech consulting is distinct from general healthcare consulting. While healthcare consulting covers hospitals, payers, and health systems, biotech consulting focuses specifically on companies that develop drugs, biologics, gene therapies, and diagnostics. The work requires an understanding of clinical trial design, regulatory pathways, and the science behind the products being commercialized.

 

The types of projects biotech consultants typically work on include:

 

• R&D portfolio prioritization: Helping clients decide which pipeline assets to invest in based on clinical probability of success, market potential, and competitive dynamics

 

• Go-to-market strategy: Designing launch plans for new drugs, including pricing, market access, and physician targeting

 

• Due diligence for M&A: Evaluating acquisition targets by assessing their pipeline, commercial potential, and regulatory risks

 

• Regulatory strategy: Advising on FDA and EMA submission pathways, clinical trial design, and approval timelines

 

• Market access and pricing: Determining how to price therapies across different countries, payers, and reimbursement systems

 

• Commercial operations: Optimizing salesforce effectiveness, distribution channels, and marketing strategy for biotech products

 

According to Grand View Research, the global biotechnology market was valued at over $1.5 trillion in 2024 and is projected to grow at roughly 14% annually through 2030. This rapid expansion creates enormous demand for consultants who can bridge the gap between cutting-edge science and real-world business execution.

 

What Does a Biotech Consultant Do Day to Day?

 

A biotech consultant spends most of their time analyzing data, building strategic recommendations, and presenting findings to senior executives at life sciences companies. The day-to-day work looks different depending on whether you work at a generalist firm like McKinsey or a specialized boutique like ClearView Healthcare Partners, but the core activities are similar.

 

On a typical engagement, you might start the week reviewing clinical trial data for a client's pipeline asset, build a financial model projecting revenues under different pricing scenarios, interview key opinion leaders (physicians who influence prescribing behavior), and then synthesize everything into a recommendation for the client's executive team. Projects usually last 8 to 16 weeks, and you will often work with a team of 3 to 5 consultants.

 

Having coached hundreds of candidates entering life sciences consulting, I can tell you the most common daily activities include:

 

• Building financial models for drug revenue forecasts, including market sizing, pricing assumptions, and patient uptake curves

 

• Conducting primary research through interviews with physicians, payers, patients, and regulatory experts

 

• Analyzing competitive landscapes to understand how rival therapies compare on efficacy, safety, and price

 

• Creating client-ready slide decks that translate complex scientific data into clear strategic recommendations

 

• Collaborating with medical affairs, regulatory, and commercial teams within client organizations

 

• Presenting findings and defending recommendations to C-suite executives, board members, and investors

 

One thing that surprises many candidates is how much client interaction biotech consulting involves. Even at the analyst level, you will often participate in client calls and present portions of the work. According to Glassdoor reviews, over 80% of life sciences consultants rate the intellectual challenge and client exposure as the most rewarding aspects of their roles.

 

Which Firms Hire Biotech Consultants?

 

Biotech consultants work at two types of firms: generalist management consulting firms with life sciences practices, and boutique firms that specialize exclusively in biotech, pharma, and healthcare. Both offer strong career paths, but the experience, client work, and culture differ significantly.

 

Which Generalist Firms Have Life Sciences Practices?

 

McKinsey, BCG, and Bain all have large, dedicated life sciences practices that serve biotech and pharmaceutical clients. McKinsey's Pharmaceuticals and Medical Products practice employs over 700 consultants globally and advises 19 of the top 20 pharma companies. BCG's biopharma practice focuses on digital health, R&D productivity, and commercial strategy. Bain's Healthcare and Life Sciences practice covers everything from portfolio strategy to operational transformation.

 

Other generalist firms with strong life sciences teams include Deloitte, Accenture, PwC, EY, and KPMG. These firms tend to handle larger transformation projects, regulatory compliance engagements, and technology-driven initiatives for pharmaceutical companies. LEK Consulting is another top-tier firm known specifically for its deep life sciences expertise.

 

Which Boutique Firms Specialize in Biotech Consulting?

 

Boutique biotech consulting firms focus exclusively on life sciences clients and tend to offer deeper industry specialization. If you want to work on biotech and pharma cases every day without being staffed on a retail or banking project, a boutique is the right choice. Here are the most prominent ones:

 

• ClearView Healthcare Partners: Specializes in market forecasting, competitive assessments, and commercialization strategy for biotech and pharma clients

 

• Putnam Associates: Focuses on pharmaceutical pricing, market access, and health economics

 

• Health Advances: Covers strategy across biopharma, diagnostics, and digital health

 

• ZS Associates: Known for salesforce effectiveness, commercial analytics, and go-to-market strategy in pharma

 

• IQVIA: Combines consulting with clinical trial services and massive healthcare data analytics capabilities

 

• Simon-Kucher: Specializes in pricing and growth strategy for life sciences and healthcare products

 

• Syneos Health Consulting: Bridges clinical development and commercial strategy under one roof

 

For a broader list, check out our guide to top boutique consulting firms, which includes several life sciences specialists.

 

How Do Generalist and Boutique Biotech Firms Compare?

 

The table below compares the key differences between working at a generalist firm's life sciences practice versus a specialized boutique biotech consulting firm.

 

Factor	Generalist Firm (MBB)	Boutique Biotech Firm
Project scope	Cross-industry; may be staffed on non-healthcare cases	100% life sciences; every project is biotech or pharma
Client types	Large pharma, payers, hospitals, biotech	Primarily biotech startups, mid-size pharma, investors
Industry depth	Broad strategic perspective; less technical detail	Deep scientific and clinical fluency required
Travel	High (4 days per week at client site is common)	Moderate (more office-based analysis)
Compensation	Higher base salary and bonus (MBB pay scales)	Competitive but generally 10-20% below MBB
Exit opportunities	Broad: pharma, VC, PE, tech, startups	Focused: pharma corporate strategy, biotech ops, VC

 

How Much Do Biotech Consultants Make?

 

Biotech consulting salaries are highly competitive, especially at the senior levels. Compensation varies based on firm type, seniority, location, and educational background. According to Glassdoor and ZipRecruiter salary data from 2026, here is what you can expect at each level.

 

Level	Base Salary	Total Comp (with Bonus)	Typical Experience
Analyst / Associate	$75,000 to $100,000	$85,000 to $120,000	0 to 2 years
Consultant	$110,000 to $150,000	$130,000 to $180,000	2 to 5 years
Manager / Project Leader	$160,000 to $220,000	$200,000 to $300,000	5 to 8 years
Partner / Principal	$300,000+	$500,000 to $2,000,000+	10+ years

 

At MBB firms (McKinsey, BCG, Bain), life sciences consultants earn the same salaries as their generalist counterparts. For example, a first-year BCG consultant earns roughly $110,000 in base salary plus a $25,000 signing bonus and a $20,000 to $35,000 performance bonus. At boutique biotech firms, base salaries tend to be 10% to 20% lower, but the specialization and work-life balance can offset the difference.

 

Candidates with PhDs, MDs, or PharmDs often command higher starting salaries. According to Indeed data, the average biotech consultant salary in the United States is approximately $133,000 per year, though this figure spans all experience levels and firm types.

 

What Biotech Industry Knowledge Do You Need?

 

You do not need to be a scientist to succeed in biotech consulting, but you do need to understand the fundamentals of how drugs are developed, approved, and commercialized. In my experience coaching candidates for life sciences consulting roles, the candidates who demonstrate even basic industry knowledge dramatically outperform those who walk in cold.

 

How Does the Drug Development Pipeline Work?

 

Every biotech consulting engagement relates back to the drug development lifecycle. Understanding this process is non-negotiable. Here is a simplified breakdown:

 

Stage	What Happens	Duration	What Consultants Do
Preclinical	Lab and animal testing to assess safety	3 to 6 years	Pipeline valuation, target identification
Phase I	Small human trials (20 to 80 patients) testing safety	1 to 2 years	Market sizing, early commercial assessment
Phase II	Larger trials (100 to 300 patients) testing efficacy	1 to 3 years	Competitive analysis, pricing strategy
Phase III	Large-scale trials (1,000+ patients) confirming efficacy	2 to 4 years	Launch planning, market access strategy
FDA Review	Regulatory submission and approval decision	6 to 18 months	Regulatory strategy, label optimization
Launch	Product enters the market	Ongoing	Go-to-market execution, salesforce design

 

According to the Tufts Center for the Study of Drug Development, the average cost to develop a new drug from discovery through approval is approximately $2.6 billion. Only about 12% of drugs that enter clinical trials ultimately receive FDA approval. These high stakes are exactly why biotech companies rely heavily on consultants.

 

What Key Concepts Should You Understand?

 

Beyond the drug development pipeline, you should be familiar with these concepts before interviewing at a biotech consulting firm:

 

• Market access and payer dynamics: How drugs get covered by insurance, formulary placement, and the role of pharmacy benefit managers

 

• Regulatory pathways: The differences between standard FDA review, Priority Review, Breakthrough Therapy designation, and Accelerated Approval

 

• Therapeutic areas: The major disease categories where biotech innovation is concentrated, including oncology, rare diseases, immunology, neurology, and gene and cell therapy

 

• Biosimilars: Lower-cost versions of biologic drugs that are entering the market as patents expire on blockbuster therapies

 

• AI in drug discovery: How machine learning is being used to identify drug targets, design molecules, and accelerate clinical trial recruitment

 

According to a BCG report, AI-enabled drug discovery could reduce development timelines by 25% to 50% and lower R&D costs significantly. GLP-1 receptor agonists (the drug class behind recent weight-loss treatments) generated over $50 billion in global revenue in 2025, making them one of the most commercially significant biotech innovations in decades.

 

How Do You Break Into Biotech Consulting?

 

Breaking into biotech consulting requires a combination of scientific knowledge, analytical ability, and case interview preparation. The recruiting process is competitive, but your path in depends on your educational background and the type of firm you are targeting.

 

What Background Do You Need?

 

There are three primary entry paths into biotech consulting, each with different advantages:

 

PhD or MD path: Candidates with doctoral degrees in biology, biochemistry, pharmacology, neuroscience, or related fields are highly valued at both boutique biotech firms and MBB life sciences practices. Your deep scientific training gives you credibility with clients and allows you to evaluate clinical data at a level that MBA candidates cannot. According to McKinsey's recruiting data, approximately 30% of their life sciences practice hires have PhD or MD backgrounds.

 

MBA path: MBA candidates enter biotech consulting through the standard consulting recruiting process at MBB and other firms. If you have pre-MBA experience in pharma, biotech, or healthcare, you will be a strong candidate for life sciences practice placement. Even without a science background, MBA candidates who demonstrate genuine interest in healthcare during interviews are regularly placed on life sciences engagements.

 

Undergraduate path: Undergraduates with degrees in biology, bioengineering, public health, or pre-med can enter boutique biotech consulting firms as analysts. Some MBB firms also hire undergrads into their life sciences practices, though this is less common. Strong analytical skills and demonstrated interest in healthcare are essential.

 

What Is the Recruiting Process?

 

The biotech consulting recruiting process follows the same general structure as traditional consulting recruiting, with a few differences depending on the firm type.

 

At MBB firms, you will apply through the standard process (resume, cover letter, online assessment) and be considered for life sciences practice placement during or after your interviews. At boutique firms like ClearView, Putnam, or Health Advances, the process is similar but cases will almost always focus on life sciences topics.

 

The typical process at most biotech consulting firms includes:

 

• Application: Submit your resume and cover letter, emphasizing any science, healthcare, or life sciences experience

 

• Online screening: Some firms use aptitude tests or screening assessments before interviews

 

• First round interviews: One to two case interviews, often focused on pharma or biotech scenarios such as drug pricing, market entry, or M&A

 

• Final round interviews: Two to four interviews mixing case interviews with behavioral and fit questions. At boutique firms, expect cases with more scientific depth

 

How Should You Prepare for Biotech Case Interviews?

 

Biotech case interviews follow the same structure as standard consulting case interviews, but the business scenarios are set in the life sciences industry. You will encounter cases about drug pricing, market entry for new therapies, M&A of biotech startups, R&D portfolio prioritization, and product launch strategy.

 

The best way to prepare is to first master the fundamentals of case interviews, then layer on biotech-specific knowledge. If you want a fast, structured way to learn case interviews, my case interview course walks you through proven strategies that you can learn in as little as 7 days.

 

The most common biotech case types you should practice include:

 

• Drug pricing: Determine the optimal price for a new therapy considering production costs, competitor pricing, payer willingness to pay, and patient access

 

• Market entry: Assess whether a biotech company should enter a new therapeutic area or geographic market

 

• M&A and due diligence: Evaluate whether a pharma company should acquire a biotech startup based on pipeline value, regulatory risk, and synergies

 

• Portfolio prioritization: Help a client decide which pipeline assets to invest in and which to deprioritize or out-license

 

• Product launch: Design a go-to-market plan for a newly approved drug, including physician targeting, payer strategy, and patient support programs

 

For practice cases with detailed solutions, check out our guides to life sciences consulting case interviews and healthcare consulting case interviews. You can also find over 100 free practice cases in our case interview examples guide.

 

What Are the Exit Opportunities from Biotech Consulting?

 

One of the biggest advantages of biotech consulting is the breadth of career paths it opens up. After 2 to 5 years in biotech consulting, you develop a rare combination of scientific knowledge, strategic thinking, and business acumen that is highly sought after across the life sciences industry.

 

The most common exit opportunities include:

 

• Corporate strategy at pharma or biotech companies: Lead strategic planning, business development, or commercial operations at companies like Pfizer, Amgen, Regeneron, or Genentech. According to LinkedIn data, this is the most common exit path for life sciences consultants.

 

• Venture capital (life sciences funds): Evaluate biotech startups and pipeline assets for investment at firms like OrbiMed, ARCH Venture Partners, or Third Rock Ventures. VCs actively recruit former biotech consultants because of their due diligence expertise.

 

• Biotech startup operations: Join an early-stage biotech company in a business development, strategy, or commercial leadership role. Many consultants are drawn to the pace and ownership that startups offer.

 

• Private equity (healthcare-focused): Work at PE firms like Welsh Carson, Danaher, or Blackstone's life sciences team, evaluating and operating portfolio companies.

 

• Business development and licensing: Manage partnerships, licensing deals, and M&A transactions for pharma companies. This role combines strategic thinking with relationship management.

 

• Medical affairs or market access: Move into specialized functions within pharma companies that require deep knowledge of disease areas, clinical evidence, and payer strategy.

 

According to a survey by Bain, over 60% of consultants who leave the firm within the first five years move into industry roles at companies they previously served as clients. Biotech consulting accelerates this transition because the networks and knowledge you build are directly transferable.

 

Frequently Asked Questions

 

Does McKinsey Do Biotech Consulting?

 

Yes. McKinsey's Pharmaceuticals and Medical Products practice is one of the largest life sciences consulting teams in the world, with over 700 consultants serving biotech, pharma, and medtech clients. McKinsey advises 19 of the top 20 global pharmaceutical companies on topics including R&D portfolio strategy, commercial launch planning, and operational transformation.

 

Is Biotech Consulting a Good Career?

 

Biotech consulting is an excellent career for people who enjoy solving complex problems at the intersection of science and business. You get exposure to cutting-edge medical innovation, competitive compensation (starting at $75,000 to $100,000 for analysts and exceeding $200,000 at the manager level), and strong exit opportunities into pharma, venture capital, and biotech startups. The main trade-offs are demanding hours and the learning curve if you come from a non-science background.

 

Can You Do Biotech Consulting Without a Science Degree?

 

Yes. While a science background gives you an advantage at boutique biotech firms, MBB firms regularly hire MBA and undergraduate candidates without science degrees into their life sciences practices. Strong analytical skills, genuine interest in healthcare, and the ability to learn scientific concepts quickly are more important than having a specific degree. Many successful biotech consultants started with economics, engineering, or business degrees.

 

What Is the Difference Between Biotech Consulting and Pharma Consulting?

 

The terms are often used interchangeably, but there is a subtle distinction. Biotech consulting focuses on companies that develop drugs using biological processes (such as gene therapy, monoclonal antibodies, and cell therapy), while pharma consulting covers the broader pharmaceutical industry including traditional chemical-based drugs. In practice, most life sciences consulting firms serve both biotech and pharma clients, so the day-to-day work overlaps significantly.

 

How Long Do Biotech Consulting Projects Typically Last?

 

Most biotech consulting projects run 8 to 16 weeks, though some can be shorter (4 to 6 weeks for focused analyses) or longer (6+ months for large transformation engagements). At MBB firms, you might rotate to a new project every 2 to 4 months. At boutique biotech firms, project durations are similar, but you are more likely to work on multiple smaller engagements simultaneously.

 

Everything You Need to Land a Consulting Offer

 

Need help passing your interviews?

• Case Interview Course: Become a top 10% case interview candidate in 7 days while saving yourself 100+ hours
  
  
• Fit Interview Course: Master 98% of consulting fit interview questions in a few hours
  
  
• Interview Coaching: Accelerate your prep with 1-on-1 coaching with Taylor Warfield, former Bain interviewer and best-selling author

  

Need help landing interviews?

• Resume Review & Editing: Craft the perfect resume with unlimited revisions and 24-hour turnaround

 

Need help with everything?

• Consulting Offer Program: Go from zero to offer-ready with a complete system

 

Not sure where to start?

• Free 40-Minute Training: Triple your chances of landing consulting interviews and 8x your chances of passing them